HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target
HC Wainwright & Co. Reiterates Buy on Reviva Pharmaceuticals, Maintains $14 Price Target
HC Wainwright & Co. 重申对Reviva Pharmaceuticals的买入评级,维持14美元的目标价
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $14 price target.
HC Wainwright & Co. 分析师Raghuram Selvaraju 重申 Reviva Pharmaceuticals (纳斯达克:RVPH) 买入评级,维持目标价14美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。